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An improved understanding of the contribution made by environmental exposures to disease
burden in children is essential, given current increasing rates of childhood illnesses such asthma
and cancer. Children must be routinely included in environmental research. Exposure
assessment, both external (e.g., air, water) and internal dose (e.g., biomarkers), is an integral
component of such research. Biomarker measurement has some advantages that are unique in
children. These include assessment of potentially increased absorption because of behaviors that
differ from adults (i.e., hand-to-mouth activity); metabolite measurement, which can help identify
age-related susceptibility differences; and improved assessment of dermal exposure, an
important exposure route in children. Environmental exposure assessment in children will require
adaption of techniques that are currently applied in adult studies as well as development of tools
and validation of strategies that are unique for children. Designs that focus on parent-child study
units provide adult comparison data and allow the parent to assist with more complex study
designs. Use of equipment that is sized appropriately for children, such as small air pumps and
badge monitors, is also important. When biomarkers are used, biologic specimens that can be
obtained noninvasively are preferable. Although the current need is primarily for small focused
studies to address specific questions and optimize research tools, the future will require
establishment of large prospective cohorts. Urban children are an important study cohort because
of relatively high morbidity observed in the urban environment. Finally, examples of completed or
possible future studies utilizing these techniques are discussed for specific exposures such as
benzene, environmental tobacco smoke, aflatoxin, volatile organic compounds, and polycyclic
aromatic hydrocarbons. - Environ Health Perspect 106(Suppl 3):827-832 (1998).
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Introduction
The number and diversity of chemical lower exposures as well. This is due to
toxicants to which humans are exposed many factors including longer exposure
have increased significantly in recent time (not just the work week or a working
decades. Traditional exposure concerns lifetime) and the fact that highlysusceptible
focused primarily on occupational expo- populations are more likely to be exposed.
sures, which generally occur at higher levels Amajorpriorityoffuture environmental
than in the community. However, environ- research is the evaluation ofthesesusceptible
mental research has shown that serious high-risk populations. Children are one of
adverse health effects may result from these the most important groups in this regard.
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There are many differences between
children and adults that are likely to result
in greater toxicity in children from similar
external environmental exposures (1). For
example, children are routinely involved in
activities that result in increased opportunity
for toxicant contact and absorption, such as
playing on the floor and hand-to-mouth
activity. They may also have decreased
detoxification capacity for many chemicals
because of metabolic enzyme differences
present during development. However,
with the exception of lead and, to some
extent, environmental tobacco smoke
(ETS), few data are available on the magni-
tude ofchildren's exposure to most envi-
ronmental toxicants. Even less information
exists to delineate the nature oftheir unique
susceptibility to these toxicants. To rem-
edy these critical data gaps, exposure assess-
ment tools and strategies suitable for
children must be developed, validated, and
refined, and environmental health studies
must routinelyinclude children.
Environmental Exposure
Assessment
Exposure represents a critical link in the
cascade ofevents that originates with envi-
ronmental contamination and may result
in adverse health outcomes. To evaluate
risk or causative associations, the link
between exposure and effect must be rigor-
ously established. This is difficult in envi-
ronmental studies where exposure levels are
low and information to assess past expo-
sures is limited. Exposure assessment in
children adds an additional complexity but
is necessary because of the many differ-
ences between children and adults, which
make extrapolation from adult data poten-
tially flawed. There are several tools that
can be utilized in exposure assessment;
their strengths and weaknesses when used
in children will be discussed.
ExternalExposureMonitoring
Exposure assessment can be conducted
through direct and/or indirect approaches.
The indirect approach relies on validated
models that evolve from well-characterized
relationships between causative variables
and exposure from studies using direct
measurements. Because there is in general a
paucity of exposure data on children and
the models for adults are not likely valid
for children, the indirect approach is not
yet reliable or appropriate for children.
Therefore, direct measurements are needed.
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Direct measurements can be obtained
in external (to an individual's body) envi-
ronmental media or through the determi-
nation ofcontaminants or their metabolites
in a biologic medium. Traditionally, expo-
sure assessment has relied on external or
ambient exposure monitoring ofairborne
toxicants. This involves measuring a chem-
ical in air either by area sampling with the
monitor in a fixed location, or by personal
monitoring in which small pumps are
worn by the monitored participants. There
are a number ofadvantages to airborne
exposure assessment. Standard assay meth-
ods with reference levels, both in the work-
place and, in some cases, environmentally,
are available for many different chemicals.
In addition such monitoring allows a
determination ofthe effectiveness ofany
exposure controls in use.
Despite its advantages, sole reliance
on airborne exposure assessment has limi-
tations as well. Monitoring may not be
representative ifwide variation in expo-
sure occurs. Airborne exposure assessment
measures only one route ofexposure, so
exposure from chemicals that can be
absorbed through the skin or ingested is
not included. These latter routes may be
particularly important in children
because of their hand-to-mouth activity
and crawling, which allow skin contact.
Infants also have a larger surface-to-vol-
ume ratio than adults, resulting in more
proportionate skin surface across which
absorption can occur (1). Another impor-
tant limitation is that exposure indicates
only the current level ofchemical present
in the environment. That level does not
always reliably predict internal dose,
which is the amount of chemical that
exposed individuals ultimately absorb
into their bodies. Differences in absorp-
tion at similar exposure levels occur for
many reasons. For example, respiratory
rate and size of the respiratory tract are
important considerations for inhaled tox-
icants. These factors also differ between
children and adults, allowing children
to inhale disproportionately more of an
airborne toxicant.
Finally, although the risk ofadverse
health outcomes increases with air level for
most toxicants, there remains signiflcant
variation in the severity ofthose outcomes
among individuals exposed at the same
level. Knowledge regarding the pathophysi-
ologic processes between exposure and dis-
ease outcome is critical in understanding
this variation and thus improving the ability
to protect exposedpopulations.
BiologicMonitoring
Biologic monitoring can be divided into
two types: internal dose, which is measure-
ment ofa chemical or its metabolite(s) in
biologic specimens such as breath, blood,
or urine; and biologically effective dose,
which is the amount of chemical or its
metabolite(s) that has interacted with criti-
cal cellular macromolecules ofthe target or
surrogate tissue. The term biomarker is
often used to refer to the specific chemicals
measured in internal or biologically effec-
tive dose assays. Incorporation of bio-
marker measurement into environmental
work substantially strengthens such
research by providing information on
individual variation in absorption and
metabolism. This variation is likely to be
an essential factor in human susceptibility
for toxic outcomes.
Several criteria have been established to
assist in the development and validation of
biomarker assays (2). These criteria are
similar to those used for clinical or other
medical screening tests and are essential for
any measurement that may ultimately be
used for clinical or surveillance purposes.
The biomarker should be biologically rele-
vant to the toxic pathway involved in
chemical metabolism. It must be feasible to
obtain. Specifically, the biologic specimen
must be accessible (e.g., urine, not organ
biopsy) and the assay must not be so time
consuming that it can only be done in a
limited number ofindividuals. Inter- and
intraindividual variation, which can be
wide in comparison to established clinical
tests, must be understood and manageable
at least to the extent that group differences
and trends over time can be assessed. The
assay must be valid and reproducible.
Finally, sensitivity, specificity, and positive
predictive value must be acceptable.
Biologic monitoring is best used in
conjunction with a questionnaire or air
monitoring to identify a population with a
wide enough exposure range to allow
meaningful interpretation of biomarker
results. Because all exposures potentially
contributing to body burden, and conse-
quently to adverse health effects, are of
interest regardless ofexposure source or
route, an integrated exposure assessment
approach is the ultimate goal. This
approach has been described and justified
by Ott (3) and Lioy (4) and exemplified
in community studies involving adult
exposures to single classes ofpollutants
including the Total Exposure Assessment
Methodology for Volatile Organic
Compounds (TEAM-VOC) Study (5), the
Nonoccupational Pesticide Exposure
Study (6), and the Total Human Environ-
mental Exposure Study (7) for polycyclic
aromatic hydrocarbons (PAHs). More
recent studies are beginning to consider
cumulative exposures across both multiple
media and pollutants (8,9).
An example of a successful internal
dose biomarker is blood lead, which has
had an enormous impact on the preven-
tion and treatment of lead exposure in
children. Experience with blood lead and
other internal dose biomarkers has revealed
a number ofadvantages. Biomarkers inte-
grate exposure from all routes and sources.
This is especially valuable for chemicals
with two or more substantial routes of
exposure from multiple media such as air,
food, and water. Their measurement
assesses the amount ofa chemical that is
ultimately absorbed into the body after the
influence of exposure factors such as
behavior, contact rates, protective mea-
sures, and differences in respiratory rate.
In addition, ifmetabolites are measured,
information on the processing of the
chemical is provided. This can ultimately
lead to a better understanding ofchemi-
cally induced disease processes and
improved protection of those at highest
risk. Unfortunately, internal dose monitor-
ing has several disadvantages as well. Few
chemicals have well-validated assays.
Individual metabolite biomarkers may be
nonspecific because of formation from
more than one parent compound. Target
organ damage, which is a more direct
measure oftoxicity, is notdetermined.
Biologically effective dose measurement
assesses damage at the target organ affected,
which is a major advantage. Carboxyhemo-
globin for carbon monoxide poisoning is a
commonly used example. Biomarkers that
determine biologically effective dose by
effects on surrogate tissues include mea-
suroment of red blood cell cholinesterase
in pesticide-exposed populations and
DNA or protein adducts in white blood
cells. The main disadvantage is that even
fewer assays have been developed and
many are quite time consuming. Also,
most biomarkers are short-term exposure
measures and do not provide information
on past levels ofexposure.
The use of biomarkers is especially
justified when a) exposures occur through
multiple routes and pathways; b) there is
significant potential for dermal absorption
or ingestion (i.e., from hand-to-mouth
activity); or c) there is a high ratio ofsam-
pling burden to subject ability (cognitive
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and physical). These criteria, outlined in
Table 1, suggest that biomarker use for
study of environmental exposures in
children could be extremely useful.
Adaption of Exposure
Assessment Techniques
for Children
Biomarkers and other exposure assessment
techniques can be adapted for use in chil-
dren in several ways. First, unique recruit-
ment strategies are needed. Pediatric clinics
and child-specific facilities such as schools
or day care are good recruitment sites.
Parental involvement in the study is
another helpful technique. This ensures
better cooperation on the part ofthe child
and parental involvement allows for a more
complex study design. In addition, because
so few biologic monitoring data are avail-
able in children, meaningful comparison
data are provided. Parent-child study pairs
are similar genetically and mayhave similar
exposures, at least on the study day.
However, the age difference remains,
which allows analysis of this important
aspect of children's susceptibility. It is
important to note that although the parent
is often the initial contact, especially for
young children, informed consent must
still be obtained from the child as well.
Consent should be appropriate for age and,
for young children, is often a simple oral
explanation in the presence ofthe parent.
Exposure monitoring can be modified
by utilizing study equipment that is appro-
priately sized for children. Smaller air
monitoring pumps are now available that
are more comfortable for children. Placing
pumps in backpacks or fanny packs is also
often acceptable to children, as many are
used to wearing these packs already. It also
uses the out-of-sight-out-of-mind princi-
ple, which helps prevent the child from
playing with equipment and potentially
affecting results. Passive badge monitoring
is a lightweight, relatively tamper-resistant
monitoring option that is of benefit in
children. The use ofactivity pattern diaries
is another technique that provides exposure
information for children; this information
can be provided by the parent over the
course of the study period, particularly
when the children are veryyoung.
Incorporation ofexposure biomarkers
into study designs provides important
additional exposure information. Bio-
marker measurement is particularly impor-
tant in children, as their absorbed dose for
a given external exposure level may be very
different from that ofan adult, thus result-
ing in a different toxic response. When
possible, the use of painless noninvasive
techniques is preferable. For example,
instead ofmeasuring a biomarker in blood,
which generally involves venipuncture, that
same or a similar biomarker can be often
be measured in urine, saliva, or breath.
Hair analysis may also have potential as
this methodology develops. The ETS bio-
marker, cotinine, is a useful biomarker in
this regard, as it can be measured in saliva,
blood, and urine. Urine specimens can be
obtained in older children who are toilet
trained. In very young children and
infants, saliva provides a more accessible
biologic specimen. Ifblood is needed, fetal
cord blood, obtained at birth, is an option
when the study focuses on exposure in
infancy. Obtaining the specimen at a regu-
larly scheduled blood draw (such as for
blood lead screening) is another option.
Breath sampling holds particular
promise for the assessment of children's
exposure because of its noninvasiveness
and potential for ease of collection com-
pared to blood and urine specimens. The
method can be applied to children as sim-
ply as blowing up a balloon. Quantitative
assessment of exposure based on breath
sampling requires a consistent collection
of the alveolar fraction or a means for
adjustment to a consistent fraction. The
latter approach may be more suitable for
children because a rigid collection proto-
col required for the former may not be
Table 1. Selected criteria for biomarker measurement in exposure assessment.
Criteria Rationale
Multiple pathways and routes of exposure Sampling ofmultiple environmental media is burdensome
and complex, increasing the likelihood for measurement
error and alteration of subject behavior
Significant potential for dermal exposure oringestion Methods forassessing external dermal exposure are not
well developed and are associated with considerable
uncertainty
Limited physical and cognitive capacity ofthe Some population subgroups such as the very old orvery
subject to participate in environmental monitoring young are physically and/ormentally limited in their
ability to participate in environmental monitoring
conducive to the limited attention span
and cognitive ability ofchildren. Within
and between sample variability in alveolar
collection can be adjusted based on the
sample's carbon dioxide (C02) concentra-
tion. Because alveolar air contains 4 to 5%
CO2 whereas ambient air contains 0.035%,
in the range of0 to 5%, the concentration
ofCO2 will be inversely proportional to the
dead air space contained in thesample. Pleil
and Lindstrom (10) used this approach to
adjust collected samples using a simplified
approach ofsingle breath collection.
Application of Biomarker
Study Designsfor Children
An increasing number ofenvironmental
studies now include children. A few exam-
ples ofcompleted or proposed work that
relate to our research areas ofinterest are
presented below to illustrate the use ofthe
exposure assessment techniques previously
discussed. Our collaborative research uti-
lizes biomarkers for benzene and ETS in
urban mothers and children. There is cur-
rent concern that inner-city populations
experience increased exposure to environ-
mental toxicants compared to suburban
areas (11). The contribution to disease
burden made by such exposures is
unknown but of obvious importance, as
these exposures are potentially preventable.
Furthermore, disease burden in inner-city
areas is disproportionately higher. In urban
Baltimore, Maryland, the focus of our
work, residents have an overall cancer mor-
tality rate of255 per 100,000, which is sig-
nificantly above the national rate of 172.8
per 100,000 (12).
Urban children may be exposed to
multiple toxicants simultaneously and/or
sequentially as they mature. Given the
child's longer life span compared to adults,
the potential adverse health effects can be
significant. Our work has focused on
chemicals selected by extent of exposure
and known toxicity. Benzene is a human
leukemogen. It is ubiquitous in the envi-
ronment and found in higher levels in
cities as compared to rural areas. Extensive
U.S. Environmental Protection Agency
(U.S. EPA) monitoring data has shown
that the largest contributors to environ-
mental exposure are tobacco smoke and
benzene in gasoline. (Benzene in gasoline
was recently reduced through U.S. EPA
regulation.) (13). On the basis ofthis U.S.
EPAwork, Wallace (13) estimated that the
majority ofbenzene-induced leukemias are
due to nonoccupational exposure (13).
ETS has been a focus because exposure in
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children increases their risk for respiratory
infections such as bronchitis and pneu-
monia, upper respiratory tract irritation,
reduced lung function, and asthma (14).
ETS also causes lung cancer in adults and
increasing evidence supports a causative role
for it in coronary artery disease. Lead is a
well-established neurotoxicant in children.
An initial study obtained questionnaire
information on sources of benzene and
ETS in 79 children who were patients in a
lead poisoning prevention clinic (15).
Urinary cotinine and trans,trans-muconic
acid (MA), metabolites of nicotine and
benzene, respectively, were measured.
Blood lead was obtained for clinical pur-
poses. As expected, the mean blood lead
level was elevated at 23.6 pg/dl. Although
smoking prevalence is higher in lower
socioeconomic populations, we were sur-
prised to find cotinine present in all but
one ofthe samples assayed. This was not a
highly sensitive assay, as evidenced by a
limit ofdetection of 1 ng/ml. Even more
striking was the fact that 79.5% ofchildren
had cotinine values .30 ng/mg creatinine,
a level consistent with household ETS
exposure (16). These elevated exposure
results are consistent with those ofOgborn
et al. (17), who examined ETS exposure in
a similar population-asthmatic children
receiving care from the pediatrics depart-
ment atJohns Hopkins (Baltimore, MD).
This suggests that inner-city children who
are overexposed to lead also have excessive
exposure to another environmental haz-
ard, ETS. In addition, the cotinine results
emphasize the strength of incorporating
biomarkers into the study design. A sin-
gle urine measurement of this well-
validated ETS biomarker revealed more
extensive ETS exposure than was apparent
on aquestionnaire alone.
Most children had more than one source
of potential benzene exposure based on
questionnaire data. MAwas present in 72%
ofsamples assayed. The mean was 176.6
ng/mg creatinine, with a wide range of
values (<limit of detection to 2579.2
ng/mg creatinine). The MA results may
indicate excessive benzene exposure.
However, because this biomarker is not
specific for benzene exposure, further vali-
dation in the environmental setting is
required for full interpretation ofthese
findings. Questionnaire benzene data com-
binedwithlead andETS biomarkers suggest
that these children had ongoing exposure to
multiple environmental toxicants.
Current work, focused on validation of
benzene metabolite biomarkers for use in
environmental exposure, utilizes many of
the techniques useful for study ofchildren
mentioned above. We are focusing our
efforts on mother-child pairs and on using
noninvasive biologic specimens such as
urine and breath.
Another environmental exposure for
which biomarkers have been utilized in
exposure assessment in children is afla-
toxin, a dietary hepatocarcinogen that is a
common contaminant of foodstuffs in
developing countries. Studies utilizing the
urinary aflatoxin-DNA adduct have
demonstrated that aflatoxin-exposed indi-
viduals who are also infected with the
hepatitis B virus are at particularly high
risk for cancer (18). The aflatoxin-albu-
min adduct has been measured in fetal
cord blood at levels that were different
than in maternal blood (19). This suggests
that the fetal liver is able to metabolize afla-
toxin, which results in carcinogenic expo-
sure to fetal liver cells. In addition, another
toxic metabolite, aflatoxin M,, has been
measured in breast milk from nursing
mothers in The Gambia, West Africa,
indicating that infants are exposed by this
route even before the child begins to con-
sume contaminated foodstuffs (20). This
early childhood aflatoxin exposure may be a
contributing factor to the relatively young
age at which hepatocellular carcinoma
occurs inadults indeveloping countries.
There are many other environmental
exposures in children that could be
addressed in studies utilizing the assessment
techniques discussed above. Contamination
ofwater supplies by VOCs is one example.
Such contamination is ubiquitous, arising
primarily from the chlorine disinfection
process ofwater containing organic mate-
rial (21,22). Hazardous waste sites and
leaking underground storage tanks are
other sources ofthese contaminants that
may enter the water supply (23). There is
increased recognition ofthe importance of
VOC water contamination in human
exposure (24). The potential hazards asso-
ciated with these contaminants include
cancer (benzene is a human carcinogen;
trichlorethylene and chloroform are animal
carcinogens) and hepatic toxicity (e.g.,
carbon tetrachloride) (25,26).
Exposure through the water medium
greatly complicates exposure assessment
because ofthe added routes ofingestion
and dermal absorption. Reliable methods
are available for assessing exposure by
inhalation and ingestion; however, there is
considerable uncertainty as to the dermal
contribution. Previous studies in adults
have shown that during a shower, the
dermal chloroform contribution is compa-
rable to inhalation (27,28). It is hypothe-
sized that children would be more highly
exposed than adults because of their high
surface-to-volume ratio (29), longer dura-
tion bathing activities, and bathing by
immersion (30). The dermal exposure con-
tribution that occurswith bathing is also of
particular interest in the context ofrisk
assessment or epidemiologic research
because there is evidence to suggest that
this route of exposure may have greater
toxicologic significance relative to inges-
tion. Inhalation and dermal uptake result
in higher dose levels to nonliver organs
because chloroform is not subject to first-
pass metabolism in the liver as occurs with
ingestion. Toxicologic studies showing
greater cancer potency for inhaled versus
ingested chloroform provides additional
evidence as to the possible importance of
exposures from bathing (31).
Data characterizing children's exposure
to chloroform and other trihalomethanes
from bathing are extremely limited, pri-
marily because oflack ofmethods for eval-
uating the dermal contribution. Biomarker
measurement is one option for improving
assessment. VOCs can be analyzed in
blood, but the collection by venipuncture
is a limitation in children. Several urinary
metabolite assays are available but these
methods generally lack sensitivity and/or
specificity when applied to environmental
exposures. However, breath sampling of
VOCs is a valid method for evaluating
environmental exposure (32,33). This
methodology is especially well suited for
children because ofits noninvasiveness and
ease withwhich samples can be collected.
Children's exposure to PAHs provides
another example. PAHs are carcinogens
that contaminate multiple environmental
media including air, food, water, soil, and
house dust, making exposure assessment
through sampling ofenvironmental media
burdensome, logistically difficult, and
expensive. In adults, research suggests that
diet is the primary route of exposure
(7,34). Similar studies characterizing chil-
dren's dietary exposure are warranted, as a
child's diet differs substantially from that
ofan adult and child diet studies have not
been conducted (35).
A second exposure pathway oflikely
concern is that of soil and house dust
ingestion. The significance ofhouse dust as
an exposure medium is well established
from lead research (36). However, only
recently have data become available that
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reveal relatively high levels of PAH
contamination (37,38). Ofthe PAH expo-
sure pathways in children, house dust is the
least characterized with the greatest expo-
sure potential. Based on limited data,
Roberts et al. (39) estimate that 65% ofan
infant's total exposure to benzo[a]pyrene
comes from house dust. Direct measure-
ments ofsoil ingestion rates using tracers
suggest that children's nondietary ingestion
is highly variable (40,41). Because of this
variability and the difficulty in quantifying
dermal absorption and hand-to-mouth
activity, a PAH biomarker is particularly
useful in assessing the house dust exposure
contribution. Urinary 1-hydroxypyrene is a
biomarker that could be utilized in such
studies. A large number ofenvironmental
and occupational exposure studies have
been conducted that have demonstrated its
validity as an exposure biomarker (42-44).
Conclusions
Inclusion ofchildren is essential in future
environmental health research. Exposure
assessment is an integral component of
such research. Comprehensive exposure
assessment requires measurement ofconta-
minants in external media and biomarkers.
The latter has some advantages that are
unique in children, such as providing
information on absorption that may
differ from adults because of different
behaviors, physiology, and metabolism.
Environmental exposure assessment in
children will require adaption of tech-
niques that are currently applied in studies
of adults as well as development and
validation oftools and strategies that are
unique for children. Although the current
need is primarily for small focused studies
to address specific questions and optimize
research tools, the future will require
establishment oflarge study cohorts to be
followed over time.
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